- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02531958
Assessment of Optimal Egg Intake in a Healthy Population
June 23, 2017 updated by: Maria Luz Fernandez, University of Connecticut
Recently, the United States Department of Agriculture (USDA) has recommended removal of the 300mg/day limit on dietary cholesterol intake due to a lack of evidence supporting a connection between cholesterol intake and increased risk for cardiovascular disease (CVD).
Previous work has shown that daily intake of eggs actually favorably alters many parameters associated with CVD risk.
Conversely, emerging research suggests that choline, a nutrient in eggs, may be converted into trimethylamine oxide (TMAO) by the intestinal microbiota.
TMAO is thought to increase the risk for CVD.
Therefore, the purpose of this study is to determine a threshold of daily egg intake at which the risk for CVD is not negatively impacted in a young, healthy population.
Study Overview
Detailed Description
The purpose of this study is to establish a threshold of egg intake at which CVD risk is not negatively altered in young, healthy individuals.
Participants (age 18-30, healthy lipid profile) will undergo a 2-week washout period followed by daily intake of 1, 2, and 3 eggs per day for 4 weeks each.
Blood samples will be collected at baseline and following each 4-week dietary period.
Samples will be analyzed to determine the impact of daily intake of increasing numbers of eggs on blood lipids, TMAO, biomarkers of oxidative stress and inflammation, and expression of cholesterol-related genes.
Study Type
Interventional
Enrollment (Actual)
38
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Connecticut
-
Storrs, Connecticut, United States, 06269
- University of Connecticut
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 30 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- BMI 18.5-29.9 kg/m2
- Proficient in English
- Cholesterol ≤ 240 mg/dL
- Willing to consume 1, 2, and 3 eggs per day for 4 weeks each
Exclusion Criteria:
- Diabetes mellitus, cardiovascular disease, history of stroke, renal disease, liver disease, cancer, or eating disorder
- Taking glucose-lowering supplements or medications
- Taking triglyceride-lowering medications, bile acid sequestrants, or high-dose chromium or cinnamon supplements
- Plasma glucose < 126 mg/dL, triglycerides > 500 mg/dL, or blood pressure > 140/90 mmHg (average of 3 readings)
- Allergy to eggs
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 1 Egg
Consumption of 1 egg per day for 4 weeks
|
Participants will complete a 2-week washout period followed by intake of 1, 2, and 3 eggs per day for 4 weeks each.
|
|
Experimental: 2 Eggs
Consumption of 2 eggs per day for 4 weeks
|
Participants will complete a 2-week washout period followed by intake of 1, 2, and 3 eggs per day for 4 weeks each.
|
|
Experimental: 3 Eggs
Consumption of 3 eggs per day for 4 weeks
|
Participants will complete a 2-week washout period followed by intake of 1, 2, and 3 eggs per day for 4 weeks each.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Plasma high-density lipoprotein (HDL)
Time Frame: 14 Weeks
|
Plasma HDL (in mg/dL) will be measured at 2, 6, 10, and 14 weeks to determine the impact of daily egg intake on HDL
|
14 Weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Plasma trimethylamine oxide (TMAO)
Time Frame: 14 Weeks
|
Plasma levels of TMAO (in µm) will be measured at weeks 2, 6, 10, and 14 to determine the extent to which daily egg intake impacts plasma TMAO concentrations
|
14 Weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Maria Luz Fernandez, PhD, University of Connecticut
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 14, 2015
Primary Completion (Actual)
December 18, 2015
Study Completion (Actual)
May 31, 2017
Study Registration Dates
First Submitted
August 20, 2015
First Submitted That Met QC Criteria
August 21, 2015
First Posted (Estimate)
August 25, 2015
Study Record Updates
Last Update Posted (Actual)
June 27, 2017
Last Update Submitted That Met QC Criteria
June 23, 2017
Last Verified
June 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- H15-227
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Disease
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruitingCardiovascular Disease (CVD) | Gender Incongruence | Cardiovascular (CV) Risk | Cardiovascular Health Status | Cardiovascular Disease Prevention | Cardiovascular Disease Acute | Cardiovascular Disease Risk FactorItaly
-
University of FloridaUniversity of Alabama at Birmingham; Brown UniversityCompletedCardiovascular Disease | Psychosocial Influence on Cardiovascular DiseaseUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedCardiovascular Disease | Inflammatory DiseaseUnited States
-
University College DublinBeacon Hospital, IrelandRecruitingCoronary Artery Disease (CAD) | Cardiovascular Diseases (CVD) | Cardiovascular Disease Prevention | Cardiovascular Disease Risk FactorIreland
-
Fu Jen Catholic UniversityRecruitingCardiovascular Disease | Cardiovascular SurgeryTaiwan
-
Istituti Clinici Scientifici Maugeri SpAA.R.C.A Associazioni Regionali Cardiologi AmbulatorialiRecruiting
-
AmgenRecruitingCardiovascular DiseaseItaly, Germany, United States, China, Japan, Spain, Denmark, Australia, France, Canada, Netherlands
-
University of ReadingBiotechnology and Biological Sciences Research Council; Royal Berkshire NHS...Not yet recruiting
-
Nanjing Medical UniversityRecruiting
-
Centre Hospitalier Universitaire de la RéunionRecruitingCardiovascular DiseaseFrance
Clinical Trials on Eggs
-
Ahmad Hussieny SalamaCompleted
-
Queen's University, BelfastCompletedSuboptimal Omega-3 IndexIreland, United Kingdom
-
North-West University, South AfricaActive, not recruitingLinear GrowthSouth Africa
-
Tufts UniversityAmerican Egg BoardCompleted
-
University of Illinois at Urbana-ChampaignEgg Nutrition CenterCompletedInflammation | ObesityUnited States
-
University of AarhusCompletedCrohn Disease | Ulcerative Colitis | Intestinal Helminthiasis
-
University of AarhusCompletedCrohn Disease | Colitis, Ulcerative | Intestinal Helminthiasis
-
Josip Juraj Strossmayer University of OsijekUnknownOmega-3 Polyunsaturated Fatty AcidsCroatia
-
Mahidol UniversityCompletedMalnutrition, ChildThailand
-
University of ManitobaEgg Farmers of CanadaRecruiting